EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation

Francesca Catarzi, Elizabeth Xin Yin Chew, Letizia Crocetti, Abigail Pearce, Ali Zaeim, Aaron Dexter, Gabriella Guerrini, Agostino Cilibrizzi, Graham Ladds, Maria Paola Giovannoni

Applied Sciences · 14.11.2026 · 16 (22) · 11301

DOI: 10.3390/app162211301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 14.11.2026. Verfasst von Francesca Catarzi und 9 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BBSRC, David James Trust Fund, Royal Society Industry Fellow.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this paper, we report the progress of our research on adenosine A1/A3 receptor antagonists, aimed at identifying new small molecules for therapeutic applications. Starting from two recently published reference compounds, we have synthesized new products with 1,8-naphthyridone scaffold performing targeted chemical modifications at positions 1 or 3. These elaborations led to compounds that maintained affinity for the inhibitory adenosine receptors A1 and A3 but lower selectivity compared to the reference compounds. The best balance between affinity and selectivity was found for 4f (pKi A1R < 4; pKi A3R = 6.25 ± 0.10) and 4i (pKi A1R = 4.91 ± 0.02; pKi A3R = 6.51 ± 0.15), whose antagonist profile and selectivity against A2AR were determined through NanoBRET binding assay. Overall, these results can be useful in guiding the optimization process of small-molecule heterocyclic A1R/A3R receptor antagonists, facilitating their future development into effective therapeutic agents.

Förderung

  • BBSRC
  • David James Trust Fund
  • Royal Society Industry Fellow

Zitieren

APA

Catarzi, F., Chew, E. X. Y., Crocetti, L., Pearce, A., Zaeim, A., Dexter, A., Guerrini, G., Cilibrizzi, A., Ladds, G., & Giovannoni, M. P. (2026). Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation. Applied Sciences, 16(22), 11301. https://doi.org/10.3390/app162211301

Vancouver

Catarzi F, Chew EXY, Crocetti L, Pearce A, Zaeim A, Dexter A, et al. Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation. Applied Sciences. 2026;16(22):11301. doi:10.3390/app162211301

BibTeX
@article{Catarzi2026,
  author = {Catarzi, Francesca and Chew, Elizabeth Xin Yin and Crocetti, Letizia and Pearce, Abigail and Zaeim, Ali and Dexter, Aaron and Guerrini, Gabriella and Cilibrizzi, Agostino and Ladds, Graham and Giovannoni, Maria Paola},
  title = {Novel 1,8-Naphthyridone Derivatives as Adenosine Receptors (ARs) Antagonists: Design, Synthesis and Biological Evaluation},
  journal = {Applied Sciences},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {11301},
  doi = {10.3390/app162211301}
}
Kostenlos starten →